Review mission to Belgrade, Serbia and Podgorica, Montenegro

The EU enlargement plan for the Western Balkans, presented by the European Commission in May, lays out conditions for the accession of Serbia and Montenegro by 2025. In order to analyse the progress made and to further strengthen cooperation with Serbia and Montenegro in the drug information area, the EMCDDA will pay a technical visit to both countries from 12–15 June 2018. During this technical visit, the EMCDDA will meet representatives of institutions and organisations tasked with monitoring and reporting on illicit drugs and new psychoactive substances (NPS). The output of the review mission will be a report summarising the observations, with possible recommendations to further strengthen the national drug monitoring system. The report will also serve as a background document to determine the countries’ progress with regard to the implementation of Chapter 24 of the EU Acquis.